Zwelling LA - Search Results

1

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

Abbruzzese JL, Madden T, Sugarman SM, Ellis AL, Loughlin S, Hess KR, Newman RA, Zwelling LA, Raber MN. Abbruzzese JL, et al. Among authors: zwelling la. Clin Cancer Res. 1996 Sep;2(9):1489-97. Clin Cancer Res. 1996. PMID: 9816325 Clinical Trial.

2

Topotecan in chronic lymphocytic leukemia.

O'Brien S, Kantarjian H, Ellis A, Zwelling L, Estey E, Keating M. O'Brien S, et al. Cancer. 1995 Mar 1;75(5):1104-8. doi: 10.1002/1097-0142(19950301)75:5<1104::aid-cncr2820750509>3.0.co;2-b. Cancer. 1995. PMID: 7850708 Clinical Trial.

3

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia.

Kantarjian HM, Beran M, Ellis A, Zwelling L, O'Brien S, Cazenave L, Koller C, Rios MB, Plunkett W, Keating MJ, et al. Kantarjian HM, et al. Blood. 1993 Mar 1;81(5):1146-51. Blood. 1993. PMID: 8382970 Free article. Clinical Trial.

4

Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.

Ellis AL, Nowak B, Plunkett W, Zwelling LA. Ellis AL, et al. Among authors: zwelling la. Cancer Chemother Pharmacol. 1994;34(3):249-56. doi: 10.1007/BF00685085. Cancer Chemother Pharmacol. 1994. PMID: 8004759

5

The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells.

Loughlin S, Gandhi V, Plunkett W, Zwelling LA. Loughlin S, et al. Among authors: zwelling la. Cancer Chemother Pharmacol. 1996;38(3):261-8. doi: 10.1007/s002800050480. Cancer Chemother Pharmacol. 1996. PMID: 8646801

6

Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.

Wassermann K, Zwelling LA, Lown JW, Hartley JA, Nishikawa K, Lin JR, Newman RA. Wassermann K, et al. Among authors: zwelling la. Cancer Res. 1990 Mar 15;50(6):1732-7. Cancer Res. 1990. PMID: 1689610

7

Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells.

Ellis AL, Zwelling LA. Ellis AL, et al. Among authors: zwelling la. Biochem Pharmacol. 1994 Nov 1;48(9):1842-5. doi: 10.1016/0006-2952(94)90472-3. Biochem Pharmacol. 1994. PMID: 7980655

8

Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.

Asano T, Zwelling LA, An T, McWatters A, Herzog CE, Mayes J, Loughlin SM, Kleinerman ES. Asano T, et al. Among authors: zwelling la. Br J Cancer. 1996 Jun;73(11):1373-80. doi: 10.1038/bjc.1996.261. Br J Cancer. 1996. PMID: 8645582 Free PMC article.

9

In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.

Andersson BS, Beran M, Bakic M, Silberman LE, Newman RA, Zwelling LA. Andersson BS, et al. Among authors: zwelling la. Cancer Res. 1987 Feb 15;47(4):1040-4. Cancer Res. 1987. PMID: 3026621

10

A possible role for altered poly(adenosine diphosphoribose)-synthesis in the sensitivity of human head and neck squamous carcinoma cells to ionizing radiation.

Wassermann K, Newman RA, McLaughlin JD, Sacks PG, Zwelling LA. Wassermann K, et al. Among authors: zwelling la. Biochem Biophys Res Commun. 1988 Aug 15;154(3):1041-6. doi: 10.1016/0006-291x(88)90245-8. Biochem Biophys Res Commun. 1988. PMID: 3408484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters